Imaginostics Awarded SBIR Grant from NIH for Translating QUTE-CE MRI Technology for Pre-Clinical Drug Development and Research Applications

The National Institute of Mental Health (NIMH) issued a notice of award on January 11, 2022, to Imaginostics, Inc., under the Small Business Innovation Research (SBIR) program to support a Phase I study entitled, “Development of a Frontier Magnetic Resonance (MR) Imaging Technology As a Tool for Visualization and Quantified Vascular-Feature Measurement for Use in Brain and Behavioral Research on Small Animals.” The research project aims to develop and optimize a software prototype implementing Imaginostics’ imaging technology for use with industry-standard small animal research scanners followed by testing and analytical characterization of biomarkers.

Imaginostics has brought together world-leading experts from academia and industry to accelerate drug development and understanding of the brain and mental illness by providing meaningful endpoints.

The research project reported here is supported by the National Institute of Mental Health of the National Institutes of Health under award number R43MH129045. The amount of federal funding for this project totals $436,556.

About Imaginostics:

Imaginostics, Inc., is a Boston-based health tech startup developing breakthrough magnetic resonance imaging (MRI) technology for precision medicine. It strives to create innovative, non-invasive diagnostic solutions using quantitative imaging biomarkers to provide new insight in health and disease. Its proprietary QUTE-CE (pronounced “cute-see”) MRI methodology can non-invasively assay vascular structure, function, and leakage in high resolution anywhere in the body, providing clinicians and scientists new endpoints for early detection and enhanced characterization of complex diseases. For more information on Imaginostics, Inc., please visit: www.imaginostics.com

This content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.